Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated Steatohepatitis
{{output}}
Background: Drug combinations have potential for additive or synergistic efficacy in patients with metabolic dysfunction-associated steatohepatitis (MASH). Aim: ... ...
